Cartalax, 20mg
Cartalax, 20mg
Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue.
-25% on everything – until October 31
25% off regular prices, replacing other product sales. Only the crypto payment discount can be combined.
Overview
Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation.
Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Properties
| Chemical Formula | C12H19N3O8 |
|---|---|
| Synonyms | T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid |
| Molar Mass | 333.29 g/mol |
| CAS Number | 205640-90-0 |
| PubChem CID | 87815447 |
| Total Compound Content | 20 mg per vial |
| Shelf Life | 36 months |
Research
Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation. Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.FAQ
What cartilage extracellular matrix markers have been examined in Cartalax research?
Research from the originating laboratory has focused on key cartilage extracellular matrix markers including collagen type II, aggrecan, and SOX9, which are central regulators of chondrocyte phenotype and cartilage matrix production. These markers are commonly used to evaluate cartilage signalling, extracellular matrix maintenance, and chondrocyte activity in experimental models.
How does Cartalax fit within the Khavinson bioregulator series?
Cartalax is the cartilage-focused member of the Khavinson peptide bioregulator series. Similar to other organ-specific bioregulators, it is proposed to influence tissue-specific regulatory pathways and is primarily investigated in studies involving cartilage biology, chondrocyte function, extracellular matrix regulation, and peptide-mediated gene expression mechanisms.
What experimental models are commonly used to investigate Cartalax?
Common models include primary chondrocyte cultures, cartilage-derived cell lines, three-dimensional cartilage culture systems, and rodent cartilage research models. Frequently measured endpoints include collagen II expression, aggrecan production, SOX9 signalling, extracellular matrix composition, glycosaminoglycan content, and chondrocyte proliferation markers.
